Author Correction: Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertension

• Shan-Shan Zhang,
• Lance Larrabee,
• Andrew H. Chang,
• Sapna Desai,
• Lisa Sloan,
• Xin Wang,
• Yixuan Wu,
• Nazia Parvez,
• Karen Amaratunga,
• Allison C. Hartman,
• Abby Whitnall,
• Joseph Mason,
• Nicholas P. Barton,
• Audrey Y. Chu,
• Jonathan M. Davitte,
• Adam J. Csakai,
• Caitlin Vestal Tibbetts,
• Audrey E. Tolbert,
• Heather O’Keefe,
• Jessie Polanco,
• Joseph Foley,
• Casey Kmett,
• Jonathan Kehler,
• Gabriela Kozejova,
• Feng Wang,
• Andrew P. Mayer,
• Patrick Koenig,
• Davide Foletti,
• Steven J. Pitts,
• Christine G. Schnackenberg

Affiliations

Shan-Shan Zhang

Therapeutics Division, 23andMe

Lance Larrabee

Therapeutics Division, 23andMe

Andrew H. Chang

Therapeutics Division, 23andMe

Sapna Desai

Medicinal Science and Technology, GSK, Medicines Research Centre

Lisa Sloan

Medicinal Science and Technology, GSK, Medicines Research Centre

Xin Wang

Research, 23andMe

Yixuan Wu

Therapeutics Division, 23andMe

Nazia Parvez

Medicinal Science and Technology, GSK, Medicines Research Centre

Karen Amaratunga

Medicinal Science and Technology, GSK, Medicines Research Centre

Allison C. Hartman

Medicinal Science and Technology, GSK

Abby Whitnall

Medicinal Science and Technology, GSK, Medicines Research Centre

Joseph Mason

Medicinal Science and Technology, GSK, Medicines Research Centre

Nicholas P. Barton

Medicinal Science and Technology, GSK, Medicines Research Centre

Audrey Y. Chu

Genomic Sciences, GSK

Jonathan M. Davitte

Genomic Sciences, GSK

Adam J. Csakai

Medicinal Science and Technology, GSK

Caitlin Vestal Tibbetts

Medicinal Science and Technology, GSK

Audrey E. Tolbert

Medicinal Science and Technology, GSK

Heather O’Keefe

Medicinal Science and Technology, GSK

Jessie Polanco

Therapeutics Division, 23andMe

Joseph Foley

Novel Human Genetics Research Unit, GSK

Casey Kmett

DMPK, GSK

Jonathan Kehler

Bioanalysis, Immunogenicity and Biomarkers, GSK

Gabriela Kozejova

Medicinal Science and Technology, GSK, Medicines Research Centre

Feng Wang

DMPK, GSK

Andrew P. Mayer

Bioanalysis, Immunogenicity and Biomarkers, GSK

Patrick Koenig

Therapeutics Division, 23andMe

Davide Foletti

Therapeutics Division, 23andMe

Steven J. Pitts

Research, 23andMe

Christine G. Schnackenberg

Novel Human Genetics Research Unit, GSK